Vibe Rounds · Guided Discovery

Decision Lab — Anemia (Full)

A commitment-gated reasoning walk-through across the diagnostic, therapeutic, and prognostic landscape of anemia — with a passive transcript mode and a printable clinical algorithm.

Disease: Anemia Chapters: Diagnosis · Therapy · Prognosis · Screening Lens: Clinical Reasoning Levels: Beginner / Intermediate / Advanced
Mode
Difficulty
Jump to

1 · Diagnosis — beginner nodes always shown; toggle difficulty above to add more

Working through classification, workup sequencing, and the microcytic / normocytic / macrocytic split.

Decision point 1 of 5
Diagnosis · Node 1Beginner

Framing a new anemia

A 34-year-old woman presents with fatigue. Hb 9.8 g/dL, MCV 68 fL, RDW 18%. No overt GI bleeding reported. Ferritin pending.

Learner selects
Order iron studies and take a focused bleeding/diet history
Attending
Correct: a microcytic, high-RDW anemia in a woman of reproductive age should prompt iron studies plus a focused bleeding/diet history — not one isolated test.

2 · Therapy / Intervention

Choosing between oral and IV iron, transfusion thresholds, ESAs, and disease-specific therapy.

Decision point 1 of 4
Therapy · Node 1Beginner

First-line therapy for straightforward IDA

Diagnosis: iron deficiency anemia secondary to menorrhagia. No GI symptoms, tolerates oral intake.

Learner selects
Start oral iron (alternate-day dosing) and refer for gynecologic evaluation
Attending
Correct — oral iron (alternate-day dosing improves absorption and tolerability) plus gynecologic referral for the menorrhagia addresses both the deficiency and its cause.

3 · Prognosis

What anemia signals about outcomes, independent of correcting the number itself.

Decision point 1 of 2
Prognosis · Node 1Beginner

Mild anemia in an elderly patient, cause unclear

82-year-old with mild normocytic anemia (Hb 10.9 g/dL). Renal function, iron studies, B12/folate, and inflammatory markers are all unremarkable.

Learner selects
Note the association with increased mortality/frailty and monitor closely
Attending
Correct — unexplained anemia in older adults is independently associated with increased mortality and frailty, even at mild severity, once nutritional, renal, and inflammatory causes are excluded.

4 · Screening & Harm

When to look for anemia proactively, and iatrogenic or drug-related contributors.

Decision point 1 of 2
Screening · Node 1Beginner

Screening in pregnancy

Antenatal clinic setting up a screening protocol for anemia across a general obstetric population.

Learner selects
Screen universally, at least once per trimester
Attending
Correct — universal screening is standard given high prevalence and low cost/harm, and is favored over risk-based approaches, which miss asymptomatic cases.

Session complete

In the full unified map, each node here would deep-link to its matching CAT entry and to adjacent labs sharing the same disease/lens tags.

5 · Clinical Algorithm — Approach to Anemia

A morphology-first pathway from initial CBC/indices to a working diagnosis. For orientation only — always confirm against current guidelines and full clinical context.

Anemia confirmed on CBC (Hb below age/sex reference range)
Check MCV — microcytic, normocytic, or macrocytic?
Microcytic (MCV <80)
Ferritin low or RDW high?
Iron deficiency anemia → find the bleeding/absorption source
RDW normal + ferritin normal?
Consider thalassemia trait → Hb electrophoresis
Normocytic (MCV 80–100)
Reticulocyte count elevated?
Yes → hemolysis or blood loss → Coombs, LDH, haptoglobin, bilirubin
No → check renal function, inflammatory markers → CKD / ACD / early marrow process
Macrocytic (MCV >100)
B12 / folate low, or marrow/liver/thyroid cause?
Megaloblastic (B12/folate deficiency) → correct B12 before/with folate
Non-megaloblastic → consider liver disease, hypothyroidism, myelodysplasia, alcohol
Unexplained or discordant picture at any branch → peripheral smear review ± bone marrow biopsy